In a mouse model of myocardial infarction, MSCs injection significantly reduced the M1 phenotype of macrophages, decreased the expression of interleukin-1β (IL-1β) and IL-6, increased the expression of IL-10, and increased alternate monocyte/macrophage activation. The gene discussed is IL10; the disease is myocardial infarction.